PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM PROVIDES IND APPLICATION UPDATE, page-61

  1. 206 Posts.
    lightbulb Created with Sketch. 44
    Whatever that ‘newly submitted non-clinical data’ is, it better be good.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.